Gene · 3438
Papers2,276
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,276
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome analysis of skeletal muscle in dermatomyositis, polymyositis, and dysferlinopathy, using a bioinformatics approach. | Front Neurol | 2023 | 38125829 | PubTator, text mining | PubMed |
| Type-I interferon pathway and DNA damage accumulation in peripheral blood of patients with psoriatic arthritis. | Front Immunol | 2023 | 38124740 | PubTator, text mining | PubMed |
| Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor radiotherapy sensitization. | Front Oncol | 2023 | 38111536 | PubTator, text mining | PubMed |
| An overview of the role of Niemann-pick C1 (NPC1) in viral infections and inhibition of viral infections through NPC1 inhibitor. | Cell Commun Signal | 2023 | 38098077 | PubTator, text mining | PubMed |
| Unmasking the Enigma of the COVID Toe. | Cureus | 2023 | 38090451 | PubTator, text mining | PubMed |
| Riding the wave of innovation: immunoinformatics in fish disease control. | PeerJ | 2023 | 38089909 | PubTator, text mining | PubMed |
| The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab. | Front Immunol | 2023 | 38077370 | PubTator, text mining | PubMed |
| The two-stage molecular scenery of SARS-CoV-2 infection with implications to disease severity: An in-silico quest. | Front Immunol | 2023 | 38077337 | PubTator, text mining | PubMed |
| Innate antiviral responses against Shaan virus infection in HEK293, A549 and MARC-145 cells and limited role of viperin against Shaan virus replication. | Heliyon | 2023 | 38076073 | PubTator, text mining | PubMed |
| In silico screening of herbal phytochemicals to develop a Rasayana for immunity against Nipah virus. | J Ayurveda Integr Med | 2023 | 38048723 | PubTator, text mining | PubMed |
| Gene interaction network analysis in multiple myeloma detects complex immune dysregulation associated with shorter survival. | Blood Cancer J | 2023 | 38030619 | PubTator, text mining | PubMed |
| Can Nitazoxanide and/or other anti-viral medications be a solution to long COVID? Case report with a brief literature review. | Clin Case Rep | 2023 | 38028066 | PubTator, text mining | PubMed |
| The Renin-Angiotensin System: The Challenge behind Autoimmune Dermatological Diseases. | Diagnostics (Basel) | 2023 | 37998534 | PubTator, text mining | PubMed |
| SMURF1 activates the cGAS/STING/IFN-1 signal axis by mediating YY1 ubiquitination to accelerate the progression of lupus nephritis. | Autoimmunity | 2023 | 37994046 | PubTator, text mining | PubMed |
| Temporal patterns of gene expression in response to inoculation with a virulent Anaplasma phagocytophilum strain in sheep. | Sci Rep | 2023 | 37989861 | PubTator, text mining | PubMed |
| Hallmarks of ageing in human skeletal muscle and implications for understanding the pathophysiology of sarcopenia in women and men. | Clin Sci (Lond) | 2023 | 37986616 | PubTator, text mining | PubMed |
| Vaccines for immune tolerance against autoimmune disease. | Adv Drug Deliv Rev | 2023 | 37980949 | PubTator, text mining | PubMed |
| Proton therapy (PT) combined with concurrent chemotherapy for locally advanced non-small cell lung cancer with negative driver genes. | Radiat Oncol | 2023 | 37974211 | PubTator, text mining | PubMed |
| Expansion of extrafollicular B and T cell subsets in childhood-onset systemic lupus erythematosus. | Front Immunol | 2023 | 37965329 | PubTator, text mining | PubMed |
| Gene expression analyses reveal differences in children's response to malaria according to their age. | bioRxiv | 2023 | 37961701 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3438/papers?page=7